Ongoing Research. Expanding Evidence.

Scientific and clinical research on vibroacoustic therapy continues to evolve across neurological, rehabilitative, pain-management, and wellness settings. LifeTone Studio regularly curates and translates emerging research into accessible Evidence Spotlights to help clients, caregivers, and organizations better understand the growing body of evidence.

Vibroacoustic Therapy (40 Hz) & Alzheimer’s Dementia

LIFETONE EVIDENCE SPOTLIGHT

A 3-year longitudinal clinical case study investigating whether 40Hz gamma-frequency Vibroacoustic Therapy (Rhythmic Sensory Stimulation) could help maintain cognition and reduce expected cognitive decline in a woman diagnosed with Alzheimer’s disease.

  • Study Details

    • Study Type: Peer-reviewed longitudinal clinical case study

    • Participants: 1 (92-year-old woman with Alzheimer’s disease)

    • Frequency Used: 40Hz gamma-frequency stimulation

    • Study Duration: 3 years

    • Session Length: Initial 45-minute clinical sessions, followed by daily in-home use

  • Methodology

    • 12 intensive clinical Vibroacoustic Therapy / RSS sessions over 4 weeks

    • 40Hz full-body auditory + vibrotactile gamma stimulation

    • Initial sessions delivered in clinical setting

    • Followed by nearly daily in-home Vibroacoustic Therapy use for 3 years

    • Repeated cognitive and behavioral assessments conducted

    Outcomes Measured:

    • MMSE (Mini Mental State Examination)

    • SLUMS cognitive testing

    • Memory assessments

    • Behavioral observations

    • Sleep

    • Caregiver interviews

    • Functional cognition tracking

  • Major Findings

    After 3 years, her MMSE score remained stable at 22/30.

    This is particularly significant because Alzheimer’s patients typically decline approximately 3.3 MMSE points annually.

    Additional Reported Benefits:

    • Maintained cognitive clarity

    • Stabilized awareness

    • Reduced behavioral dysregulation

    • Improved sleep

    • Improved short-term memory indicators

    • Reduced frustration and tantrums

    • Sustained quality of life beyond expected progression patterns

  • This peer-reviewed longitudinal clinical case study supports Vibroacoustic Therapy / Rhythmic Sensory Stimulation as a promising modality for helping maintain cognition and potentially reduce expected cognitive decline in Alzheimer’s disease.

  • This research suggests frequency-specific Vibroacoustic Therapy may offer meaningful support for:

    • Alzheimer’s support

    • Cognitive maintenance

    • Caregiver support strategies

    • Neurological wellness

    • Behavioral regulation

    • Nervous system support

    • Long-term quality of life

  • Published In

    Music & Medicine (2017)

    DOI

    10.47513/mmd.v9i3.565

    Full Citation

    Clements-Cortes, A., Ahonen, H., Evans, M., Tang-Wai, D., Freedman, M., & Bartel, L. (2017). Can Rhythmic Sensory Stimulation Decrease Cognitive Decline in Alzheimer’s Disease? A Clinical Case Study. Music & Medicine, 9(3), 174–177.

    Research Access

    Official journal abstract page / publication access: https://mmd.iammonline.com/index.php/musmed/article/view/565

Explore Published Research
Explore Published Research

LIFETONE EVIDENCE SPOTLIGHT

Vibroacoustic Therapy (40 Hz) & Fibromyalgia

A clinical study investigating whether 40Hz low-frequency sound stimulation (LFSS), a form of Vibroacoustic Therapy, could significantly reduce fibromyalgia symptoms, improve sleep, reduce pain, enhance function, and improve quality of life in women diagnosed with fibromyalgia.

    • Study Type: Peer-reviewed open-label clinical study

    • Participants: 19 women

    • Median Age: 51

    • Frequency Used: 40Hz

    • Study Duration: 5 weeks

    • Session Length: 23 minutes

  • Methodology

    • 10 Vibroacoustic Therapy sessions over 5 weeks

    • Twice-weekly treatments

    • 40Hz full-body low-frequency sound stimulation

    • Participants rested in supine position

    • Repeated measures taken before and after intervention

    Outcomes Measured:

    • Fibromyalgia Impact Questionnaire (FIQ)

    • Jenkins Sleep Scale

    • Pain Disability Index

    • Sitting and standing tolerance

    • Cervical range of motion

    • Muscle tone

    • Medication use

  • Major Findings

    • 81% improvement in Fibromyalgia Impact Questionnaire scores

    • 90% improvement in sleep scores

    • 49% reduction in pain disability

    Additional Reported Benefits

    • Significant reduction in pain

    • Improved mood

    • Improved activities of daily living

    • Increased sitting tolerance

    • Increased standing tolerance

    • Improved cervical mobility

    • Reduced muscle hypertonicity

    • No adverse effects reported

    • 73.68% reduced medication use

    • 26.32% completely discontinued pain medication

  • This peer-reviewed clinical study found that Vibroacoustic Therapy produced statistically and clinically significant improvements in fibromyalgia symptoms, sleep, mobility, pain, muscle tone, and medication reduction, supporting its role as a promising non-pharmacological therapeutic intervention.

  • This research suggests Vibroacoustic Therapy may offer meaningful support for:

    • Chronic pain management

    • Fibromyalgia symptom reduction

    • Sleep support

    • Functional mobility

    • Medication reduction

    • Nervous system regulation

    • Quality of life enhancement

  • Published In

    Pain Research and Management (2015)

    DOI

    10.1155/2015/981425

    Full Citation

    Naghdi, L., Ahonen, H., Macario, P., & Bartel, L. (2015). The effect of low-frequency sound stimulation on patients with fibromyalgia: A clinical study. Pain Research and Management, 20(1), e21–e27.

    Research Access

    Open-access full clinical article available via PubMed Central: https://pmc.ncbi.nlm.nih.gov/articles/PMC4325896/

Explore Published Research
Explore Published Research